dr. J. van Zanten

No picture available
E-mail:
j.van.zanten umcg.nl

Research

Publications
  1. GMP manufacturing of Vvax001, a therapeutic anti-HPV vaccine based on recombinant viral particles

    Jorritsma-Smit, A., van Zanten, C. J., Schoemaker, J., Meulenberg, J. J. M., Touw, D. J., Kosterink, J. G. W., Nijman, H. W., Daemen, T. & Allersma, D. P., 15-Feb-2020, In : European Journal of Pharmaceutical Sciences. 143, 8 p., 105096.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Immunity to human cytomegalovirus after organstransplantation

    Zanten, J. V., 1996, s.n.. 135 p.

    Research output: ThesisThesis fully internal (DIV)

  3. Proliferative t-cell responses to 4 human cytomegalovirus-specific proteins in healthy-subjects and solid-organ transplant recipients

    van Zanten, J., Harmsen, M. C., van der Meer, P., van der Bij, W., van Son, W. J., van der Giessen, M., Prop, J., de Leij, L. & The, T. H., Sep-1995, In : Journal of infectious diseases. 172, 3, p. 879-882 4 p.

    Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

  4. Comparative immunoblot analysis with 10 different, partially overlapping recombinant fusion proteins derived from 5 different cytomegalovirus proteins

    van Zanten, J., LAZZAROTTO, T., CAMPISI, B., VORNHAGEN, R., JAHN, G., LANDINI, MP. & The, T. H., Apr-1995, In : Microbiologica. 18, 2, p. 223-228 6 p.

    Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

View all (20) »

ID: 172914